论文信息 - CC-486 (Oral Azacitidine) in Patients with Hematological Malignancies Who Had Received Prior Treatment with Injectable Hypomethylating Agents (HMAs): Results from Phase 1/2 CC-486 Studies - 字舞流文

CC-486 (Oral Azacitidine) in Patients with Hematological Malignancies Who Had Received Prior Treatment with Injectable Hypomethylating Agents (HMAs): Results from Phase 1/2 CC-486 Studies

B. Skikne | G. Garcia-Manero | S. Gore | C. Cogle | M. Savona | B. Scott | Qian Dong | P. Conkling | T. Boyd | S. Ukrainskyj | J. Hetzer | Keshava Kumar